← Browse by Condition
Medical Condition

liver cancer

Total Trials
15
Recruiting Now
15
Trial Phases
Phase 2, Phase 1, Phase 2, Phase 3
NCT06482801 Phase 2
Recruiting

Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via IT

Enrollment
90 pts
Location
China
Sponsor
Second Affiliated Hospital of ...
View Trial →
NCT05913141
Recruiting

PDO/PDO-TIL/PDOTS for Drug Screen

Enrollment
30 pts
Location
China
Sponsor
Shanghai Zhongshan Hospital
View Trial →
NCT06326502 Phase 1
Recruiting

A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma

Enrollment
50 pts
Location
South Korea
Sponsor
Etnova Therapeutics Corp.
View Trial →
NCT06179602
Recruiting

Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors

Enrollment
1,500 pts
Location
Netherlands
Sponsor
Leiden University Medical Cent...
View Trial →
NCT06139042
Recruiting

Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers

Enrollment
1,608 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...
View Trial →
NCT06440005 Phase 1
Recruiting

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Enrollment
80 pts
Location
United States
Sponsor
Angiex, Inc.
View Trial →
NCT07327489
Recruiting

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies

Enrollment
2,000 pts
Location
United States
Sponsor
Elephas
View Trial →
NCT06873659 Phase 1
Recruiting

SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Enrollment
96 pts
Location
China
Sponsor
Qurgen Inc.
View Trial →
NCT06114082 Phase 2
Recruiting

TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients with Hepatocellular Carcinoma

Enrollment
128 pts
Location
South Korea
Sponsor
Seoul National University Hosp...
View Trial →
NCT04690972
Recruiting

"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".

Enrollment
800 pts
Location
France
Sponsor
Institut National de la Santé ...
View Trial →
NCT06580002 Phase 2
Recruiting

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Enrollment
51 pts
Location
United States
Sponsor
University of California, Irvi...
View Trial →
NCT05517811
Recruiting

Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection

Enrollment
400 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT04145141
Recruiting

National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer

Enrollment
500 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
View Trial →
NCT06478108 Phase 2, Phase 3
Recruiting

Interventional Software for Multi-immunotherapy of Solid Tumors

Enrollment
60 pts
Location
China
Sponsor
Second Affiliated Hospital of ...
View Trial →
NCT04868149 Phase 3
Recruiting

Clinical Outcome and Future Liver Remnant Regenerative Response in Laparoscopic Versus Open ALPPS

Enrollment
40 pts
Location
Hong Kong
Sponsor
The University of Hong Kong
View Trial →